These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13807568)

  • 61. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies.
    Herwaldt BL; Berman JD
    Am J Trop Med Hyg; 1992 Mar; 46(3):296-306. PubMed ID: 1313656
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chemotherapeutic and toxic activity of the antifungal agent X-5079C in experimental mycoses.
    EMMONS CW
    Am Rev Respir Dis; 1961 Oct; 84():507-13. PubMed ID: 13696713
    [No Abstract]   [Full Text] [Related]  

  • 63. Visceral leishmaniasis unresponsive to antimonial drugs. I. Clinical and immunological studies.
    Bryceson AD; Chulay JD; Ho M; Mugambii M; Were JB; Muigai R; Chunge C; Gachihi G; Meme J; Anabwani G
    Trans R Soc Trop Med Hyg; 1985; 79(5):700-4. PubMed ID: 3006294
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Azotemic nephritis during antimony therapy of a case of infantile visceral leishmaniasis].
    CHARLAS R; BENABADJI A
    Maroc Med; 1962 Dec; 41():1180-2. PubMed ID: 14020224
    [No Abstract]   [Full Text] [Related]  

  • 65. Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis.
    Murray HW
    Acta Trop; 2005 Mar; 93(3):295-301. PubMed ID: 15716043
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Attempts at the discovery of new fungistatics. II. Nitro compounds].
    ZSOLNAI T
    Biochem Pharmacol; 1961 Feb; 5():287-304. PubMed ID: 13788837
    [No Abstract]   [Full Text] [Related]  

  • 67. Treatment of post-kala-azar dermal leishmaniasis with methyl glucamine antimoniate.
    SEN GUPTA PC; BHATTACHARYYA B; DAS AK; SANYAL NN
    J Trop Med Hyg; 1952 Sep; 55(9):205-8. PubMed ID: 13011855
    [No Abstract]   [Full Text] [Related]  

  • 68. Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis.
    Roberts WL; Hariprashad J; Rainey PM; Murray HW
    Am J Trop Med Hyg; 1996 Oct; 55(4):444-6. PubMed ID: 8916804
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hozene: an antifungal detergent for hosiery.
    JUDIS J
    J Am Podiatry Assoc; 1959 Oct; 49():437-41. PubMed ID: 14408083
    [No Abstract]   [Full Text] [Related]  

  • 70. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis.
    Faraut-Gambarelli F; Piarroux R; Deniau M; Giusiano B; Marty P; Michel G; Faugère B; Dumon H
    Antimicrob Agents Chemother; 1997 Apr; 41(4):827-30. PubMed ID: 9087498
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Short term treatment of visceral leishmaniasis of the Old World with low dose interferon gamma and pentavalent antimony.
    van Lunzen J; Kern P; Schmitz J; Brzoska J; Flessenkämper S; Dietrich M
    Infection; 1993; 21(6):362-6. PubMed ID: 8132364
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis.
    Al-Abdely HM; Graybill JR; Bocanegra R; Najvar L; Montalbo E; Regen SL; Melby PC
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2542-8. PubMed ID: 9756753
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Antimony resistance in the treatment of visceral leishmaniasis].
    MIRZOIAN NA
    Med Parazitol (Mosk); 1957; 26(3):277-80. PubMed ID: 13482777
    [No Abstract]   [Full Text] [Related]  

  • 74. Antifungal activity of decanoic hydroxamic acid.
    GALE GR; BERNHEIM F; WELCH AM
    Proc Soc Exp Biol Med; 1962 Jan; 109():188-92. PubMed ID: 13896335
    [No Abstract]   [Full Text] [Related]  

  • 75. Studies on antifungal activity of variotin.
    MATSUDA A; HACHIYA N; KAWAMURA Y
    J Antibiot (Tokyo); 1959 Sep; 12():203-9. PubMed ID: 13853852
    [No Abstract]   [Full Text] [Related]  

  • 76. Amphotericin B and griseofulvin in the treatment of experimental systemic mycoses.
    EMMONS CW; PIGGOTT W
    Antibiot Chemother (Northfield); 1959 Sep; 9():550-6. PubMed ID: 13820210
    [No Abstract]   [Full Text] [Related]  

  • 77. Pharmacological studies on antifungal antibiotic, moldcidin B.
    ARATANI H; NAKAGAWA A; TATEISHI H
    J Antibiot (Tokyo); 1961 Jul; 14():199-204. PubMed ID: 14448359
    [No Abstract]   [Full Text] [Related]  

  • 78. Estimation of efficiency of fungitoxic compounds according to the inhibition of mycelium growth.
    BOMAR M
    Folia Microbiol (Praha); 1962 May; 7():185-90. PubMed ID: 13870868
    [No Abstract]   [Full Text] [Related]  

  • 79. [ANOTHER 3 PROVEN CASES OF KALA-AZAR IN THE ZARAZA DISTRICT, STATE OF GU'ARICO, INCLUDING A FATAL CASE].
    TORREALBA JF; TORREALBA JW; RAMOS I; REQUENAOSORIO C; LEMOINE M
    Gac Med Caracas; 1963; 71():113-6. PubMed ID: 14112046
    [No Abstract]   [Full Text] [Related]  

  • 80. Activity of variotin, a new antifungal antibiotic.
    SUZUKI S; SUGANUMA A; KISHIDA T; MIZUNOYA A; UEDA F; SUZUKI Y; KIJI I; KYO T; TAKEUCHI M; NAKAZAWA S; KISHI N; TSUMURA S
    J Antibiot (Tokyo); 1959 Sep; 12():244-8. PubMed ID: 13854985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.